BackgroundIn clinical research, the most appropriate way to assess the effect of an intervention is to conduct a randomized controlled trial (RCT). In the field of rare diseases, conducting an RCT is
A major challenge for rare disease clinical trials is the limited amount of available information for making robust statistical inference. While external data presents information integration opportun